IDO1, a therapeutic target in depression, metabolizes tryptophan to KYN and is upregulated during pro-inflammatory states induced by several cytokines (IL-1β, IL-6, IFN-α, TNF-α) [51, 52]. Here, IDO1 is linked to depressive disorder.